Fendler et al. also prospectively assessed the accuracy of 68Ga-PSMA PET in patients with BCR after RT and/or RP and established high positive predictive value, detection rate, and inter-reader agreement for the localization of recurrent prostate cancer with PSMA PET [20]. The gene discussed is FOLH1; the disease is prostate cancer.